Moreover, gastric cancer patients who received immune-enhanced enteral nutrition showed significant increases in IgM, NK cell, and albumin levels (53, 54), indicating that IgM levels not only reflect recent immune responses but are also influenced by the patient’s current nutritional status and degree of obesity. The gene discussed is CD40LG; the disease is gastric cancer.